Health Care Costs in Patients According to Work Ability at Celiac Disease Diagnosis: A Nationwide Cost-of-illness Study
Patients with impaired work ability at CeD diagnosis face a greater and more persistent economic burden than those with sustained work ability. The over-representation of non-CeD-related health care costs among them warrants personalized, multidisciplinary care to mitigate their multifactorial burdens.
Authors
- Mariel Arvizu (ORCID: https://orcid.org/0000-0003-1860-7276)
- Daniel A. Leffler (ORCID: https://orcid.org/0000-0002-0750-3386)
- Peter H.R. Green
- Soran Rabin Bozorg (ORCID: https://orcid.org/0000-0003-2862-8855)
- Jiangwei Sun (ORCID: https://orcid.org/0000-0003-2252-684X)
- Benjamin Lebwohl (ORCID: https://orcid.org/0000-0001-9422-4774)
- Jonas Filip Ludvigsson (ORCID: https://orcid.org/0000-0003-1024-5602)
- Jialu Yao (ORCID: https://orcid.org/0009-0004-2238-6810)
Institutions
- Beth Israel Deaconess Medical Center (US)
- Karolinska University Hospital (SE)
- Örebro University (SE)
- Columbia University Irving Medical Center (US)
- Karolinska Institutet (SE)
- Takeda (United States) (US)
- Columbia University (US)
Publication Details
- Journal
- Clinical Gastroenterology and Hepatology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1016/j.cgh.2025.12.003
- Primary Topic
- Celiac Disease Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00